Page last updated: 2024-09-04

ruboxistaurin and Angor Pectoris

ruboxistaurin has been researched along with Angor Pectoris in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benson, C; Seger, M; Voelker, J	1

Trials

1 trial(s) available for ruboxistaurin and Angor Pectoris

Article	Year
Inhibition of PKC beta by ruboxistaurin does not enhance the acute blood pressure response to nitroglycerin. Clinical pharmacology and therapeutics, 2007, Volume: 82, Issue:2 Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Angina Pectoris; Blood Pressure; Chronic Disease; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Interactions; Enzyme Inhibitors; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypotension, Orthostatic; Indoles; Infusions, Intravenous; Male; Maleimides; Middle Aged; Nitroglycerin; Protein Kinase C; Protein Kinase C beta; Treatment Outcome; Vasodilator Agents	2007

Article

Year

Inhibition of PKC beta by ruboxistaurin does not enhance the acute blood pressure response to nitroglycerin.

Clinical pharmacology and therapeutics, 2007, Volume: 82, Issue:2

Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Angina Pectoris; Blood Pressure; Chronic Disease; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Interactions; Enzyme Inhibitors; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypotension, Orthostatic; Indoles; Infusions, Intravenous; Male; Maleimides; Middle Aged; Nitroglycerin; Protein Kinase C; Protein Kinase C beta; Treatment Outcome; Vasodilator Agents

2007